guanethidine has been researched along with Bladder Disorder, Neurogenic in 2 studies
Guanethidine: An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.
guanethidine : A member of the class of guanidines in which one of the hydrogens of the amino group has been replaced by a 2-azocan-1-ylethyl group.
guanethidine sulfate : A organic sulfate salt composed of two molecules of guanethidine and one of sulfuric acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Finkbeiner, AE | 1 |
| Welch, LT | 1 |
| Bissada, NK | 1 |
| Gjone, R | 1 |
2 other studies available for guanethidine and Bladder Disorder, Neurogenic
| Article | Year |
|---|---|
Uropharmacology: XI. Adrenergic-blocking agents and drugs affecting catecholamine binding and release.
Topics: Adrenergic Agents; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Bretylium Com | 1979 |
[Treatment of acute bladder paralysis following spinal cord lesions. Experiments with guanethidine].
Topics: Animals; Guanethidine; Humans; Paralysis; Parasympathetic Nervous System; Spinal Injuries; Sympathet | 1967 |